Targeting Yersinia pestis with Small-Molecule Inhibitors of the YscN ATPase
Author Information
Author(s): Swietnicki Wieslaw, Carmany Daniel, Retford Michael, Guelta Mark, Dorsey Russell, Bozue Joel, Lee Michael S., Olson Mark A.
Primary Institution: The Uniformed Services University, Bethesda, Maryland, United States of America
Hypothesis
Can small-molecule inhibitors effectively target the YscN ATPase in Yersinia pestis to attenuate its virulence?
Conclusion
The study demonstrates that targeting the YscN ATPase can significantly attenuate the virulence of Yersinia pestis, suggesting a potential therapeutic strategy against plague.
Supporting Evidence
- Deletion of the yscN gene in Yersinia pestis resulted in over three million-fold attenuation in virulence in a mouse model.
- Small molecules were identified that inhibited YscN ATPase activity at concentrations below 20 µM.
- The compounds also inhibited YopE secretion in bacterial cell cultures.
- The study suggests that targeting T3SS ATPases could be a broad-spectrum therapeutic strategy against various pathogens.
Takeaway
Scientists found a way to make a germ that causes plague much weaker by blocking a specific part of it with tiny molecules, which could help in treating infections.
Methodology
The study involved deleting the yscN gene in Yersinia pestis and testing small molecules for their ability to inhibit the YscN ATPase activity and virulence in a mouse model.
Limitations
The study did not test the bioavailability of the compounds directly in vivo.
Participant Demographics
Swiss-Webster female mice were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website